Market Cap - 352,302 - 09/25/2019
Authorized Shares - 990,000,000 - 09/03/2019
Outstanding Shares - 57,337,505 - 09/18/2019
Institutional Holders - 22,229,210 - 09/18/2019
Float - 35,108,295 - 09/18/2019
Ozop Surgical Corp. invents, designs, develops, manufactures and globally distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties. Our focus is on economically disrupting the market with clinically equivalent or superior existing and new products resulting in immediate and significant savings for providers, payors and consumers.
The Company published 4 new video presentations on 09/11/2019
THE OZOP SURGICAL STORY
Ozop Surgical Corp. (OTCQB:OZSC), invents, designs, develops, manufactures, and distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies focused on spine, neurological, and pain management procedures and specialties. Our mission is to economically disrupt the orthopedic and neurosurgical markets by providing premium quality surgical devices that result in immediate significant savings for providers, payors, and patients; and to continue to design and manufacture cutting-edge surgical solutions, with an emphasis on our innovations in the rapidly growing field of minimally invasive surgery.
The Company controls an IP portfolio of innovative products and technologies that it is beginning to successfully commercialize. Products in the pipeline include visualization tools for MIS, such as light filtration that presents a better anatomical view of the surgical field in real time, and 3D technology that offers improved depth perception, better visualization of anatomic details, and improved overall surgical performance. Also in development is a revolutionary orthopedic device and procedure, the first truly MIS interbody device and fusion procedure.
OZOP SURGICAL EXECUTIVE MANAGEMENT TEAM
Michael Chermak, CEO, Chairman
Michael Chermak has over 30 years of experience in healthcare-related ventures. Previously, he was the founder and CEO of Healthdemographics, Inc., a company in the healthcare predictive data and decision support business. Healthdemographics had over 1,200 clients worldwide and was regularly cited by the Wall Street Journal in articles about the healthcare industry. He sold the company in 1997 to Medirisk.
In 1998, he was the co-founder, initial investor, and original Chairman of Medibuy.com, an Internet healthcare supply vendor. Medibuy raised over $140 million in its first 18 months of operation backed by leading VCs such as Kleiner Perkins, Sequoia, Oak, and institutional investors including Alianz. Medibuy acquired the ecommerce initiatives of two leading GPOs, Premier and Columbia HCA, that at one time accounted for nearly 70% of healthcare product expenditures in the US. Medibuy was sold to GHX (Global Health Exchange), an ecommerce company founded by General Electric, Abbot, Baxter, Medtronic. Becton-Dickinson, Braun, Guidant, Tyco, Siemens, and others.
He worked in China for over 6 years and was the former Chairman and CEO of Bridgetech Holdings International (OTC: BGTH), which focused on introducing Western medicine into China. He has served on the Board of Directors and as an Audit Committee member of Beijing Origin Seed (NASDAQ: SEED).
Michael graduated from the University of New Mexico, Anderson School of Management. Michael and his wife fund and run a 501(c)(3) focused on animal rescue and the support of rescue organizations.
Tom McLeer, Chief Operating Officer, Director
Tom McLeer brings over 30 years of commercial operations experience in orthopedics, spine and orthobiologics. He is a proven medical device leader who has boosted sales for existing companies and led startups through regulatory approval and into full commercialization. He holds numerous patents in the spine and orthopedic space.
He most recently served as Vice President of Sales and Marketing at LinkSpine. Previously he was Senior Vice President of US Commercial Operations for Alphatec Spine, Global CMO and General Manager of Spinal Operations for Pioneer Surgical (sold to RTI) and VP of Sales and Marketing for Archus Orthopedics. Earlier in his career, McLeer was VP of Marketing and Business Development for Spinal Concepts (sold to Abbott labs) and VP of Marketing for Interpore Cross International.
Tom holds a B.S. in Business Administration from The Ohio State University and a MBA from the Kellogg School of Management at Northwestern University.
Barry Hollander, Chief Financial Officer
Barry Hollander has 38 years of business experience, including 20 years as Chief Financial Officer of various private and public companies. In 2010, Mr. Hollander founded Venture Equity, LLC, a Florida-based company that offers financial and business consulting services. He was named Chief Financial Officer of Cabinet Grow, Inc. (“CBNT”) on May 14, 2014, and is also the current CEO of CBNT. Since 2011, Mr. Hollander has been the Chief Financial Officer of Agritek Holdings, Inc. (“Agritek”), formerly known as MediSwipe, Inc. Agritek provides real estate management and health and wellness product lines for the medicinal marijuana industry.
Barry began his career in 1981 in the accounting department of Macgregor Sporting Goods, and rose through the ranks to become a critical part of the executive management team. Over his career, Barry contributed to mergers and acquisitions, assisting companies preparing to go public and taking on public reporting responsibilities. He holds a degree from Fairleigh Dickinson University.
Nick Ansari, Executive Vice President, Sales & Marketing
Nick Ansari has more than 25 years of experience in the medical device field. Over the course of his career, he has amassed an impressive track record in defining strategies and executing initiatives that drive revenue and strengthen market shares for startup, turnaround, and rapid-growth medical device companies. Nick has an in-depth understanding of markets, products, customers, and competitors, which helps him deliver strategic and tactical blueprints to ensure success in US and international environments. He leverages his comprehensive experience in business development, P&L management, strategic planning, forecasting, sales force leadership, asset analysis, product training, and market expansion to exceed projections time and again.
Nick has previously held senior leadership positions in various medical device companies, including Stryker, Medtronic, Globus, and Lanx/Biomet-Zimmer. As an executive-level team player, he has assisted mergers and acquisitions in the private and public medical device sectors—namely, when Biomet, ZBH purchased Lanx ($147 million); when RSLS, Reshape Lifesciences purchased Bario Surge; and when RSLS purchased Lap-Band from Apollo Endosurgery, APEN.
Eric Siu, Director of Endoscopic Program Development
Eric Siu has been focused on endoscopic surgical approaches for more than 25 years. He has spent over a decade creating IP and developing minimally invasive endoscopic products, including four different neuroendoscopic systems (Viewing Endoscope, Pituitary Endoscope, Intraventricular Endoscope, Subcortical Space endoscope with visible tube) and four types of spine endoscopes (MED, MED with retractor, PELD and Cervical). Eric currently holds dozens of patents in the PRC and abroad.
OZOP is an extension of his expertise on Spine and Neuro endoscopes; and his focus on molecular MIS recognizes the future potential for endoscope systems. His experience in product development and in the laboratory add stability and bring tremendous value to the company as it pursues its great future.
Eric has established academic research collaborations with the Chinese University of Hong Kong and Hong Kong University as well as leading institutions in the PRC. He has a long history of collaboration with the MOH (Ministry of Health), where he has organized over 200 workshops for leading Chinese surgeons working with international medical device manufacturers as well as the CDA (Chinese Doctors Association) regarding physician and surgeon training and continuing education initiatives. He also has extensive experience in working with China’s regulatory body, the CFDA, and has successfully registered over 100 products for international medical devices manufacturers.
Eric has maintained an office in Tuttlingen, Germany for over 15 years; from that location, he has sourced products for introduction and sale in the PRC. Eric, a Canadian citizen based in Hong Kong and Beijing, holds degrees in Applied Mathematics and Physics from the University of London.
For distributor inquiries, please email:
If you have products that you would like us to distribute:
For all other inquiries:
Prager Metis CPAs LLC
15 Warren Street
Hackensack, NJ 07601
Anthony L.G., PLLC
330 Clematis Street
West Palm Beach, FL 33401
OTC DISCLOSURE & NEWS SERVICE